IP Library Patent Application 11670749
Patent Application
App. No. 11/670,749

CALCIUM PHOSPHATE SALTS IN ORAL COMPOSITIONS SUITABLE AS A TOOTH REMINERALIZING AGENT

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/670,749
Filed
Feb 2, 2007
Art Unit
1612
USPC
424/57
Abstract

The present invention is generally directed to an oral composition comprising a calcium phosphate salt and a combination of acids having differing solubilities in the oral cavity, for tooth mineralization or remineralization. The presence of a combination of acids in the oral composition acts to maximize the release of calcium and phosphate ions from the oral composition over an extended period of time, in order to promote the precipitation of enamel-like crystals on the surfaces of the teeth, or in subsurface regions therein.

Claims (25)

1 . An oral composition comprising a calcium phosphate salt, a first acid and a second acid, wherein upon placement of said composition in an oral cavity dissolution of said first acid begins prior to dissolution of said second acid.

2 . The oral composition of claim 1 , wherein said oral composition is a chewing gum, a candy, a confection, a tablet, a gel, a toothpaste or a dentifrice.

3 . The oral composition of claim 2 , wherein said oral composition is a chewing gum.

4 . The oral composition of claim 1 , wherein said calcium phosphate salt is selected from the group of tetracalcium phosphate, anhydrous dicalcium phosphate, tricalcium phosphate, hydroxyapatite, octacalcium phosphate, and monocalcium phosphate and combinations thereof.

5 . The oral composition of claim 1 , wherein said calcium phosphate salt is a combination of tetracalcium phosphate and anhydrous dicalcium phosphate.

6 . The oral composition of claim 1 , wherein said composition comprises at least about 0.5 percent and less than about 10 percent of the calcium phosphate salt, based on the total weight of the composition.

7 . The oral composition of claim 6 , wherein said composition comprises a combination of tetracalcium phosphate and anhydrous dicalcium phosphate, said composition comprising at least about 0.5 percent and less than about 10 percent of the combination, based on the total weight of the composition.

8 . The oral composition of claim 7 , wherein said composition comprises a weight ratio of tetracalcium phosphate to anhydrous dicalcium phosphate of greater than about 1:1, tetracalcium phosphate being in excess.

9 . The oral composition of claim 1 , wherein said first acid has a solubility of at least about 25 weight percent in water at room temperature.

10 . The oral composition of claim 9 , wherein the first acid is selected from the group consisting of citric acid, succinic acid, tannic acid, lactic acid, ascorbic acid, gluconic acid, acetic acid, malic acid, tartaric acid and salts thereof.

11 . The oral composition of claim 1 , wherein said second acid has a solubility of less than about 20 weight percent in water at room temperature.

12 . The oral composition of claim 11 , wherein the second acid is selected from the group consisting of adipic acid, fumaric acid, poylglutamic acid, polyaspartic acid, propionic acid, alginic acid, stearic acid, glutamic acid, aspartic acid, fatty acids, and salts thereof.

13 . The oral composition of claim 1 , wherein said composition has a total acid content of greater than about 0.5 weight percent and less than about 5 weight percent, based on the total weight of the composition.

14 . The oral composition of claim 1 , wherein the weight ratio of the first acid to the second acid is greater than about 1:1, with the first acid being in excess.

15 . The oral composition of claim 1 , wherein the first acid is citric acid, and the second acid is fumaric acid.

16 . The oral composition of claim 1 , wherein said composition further comprises magnesium stearate.

17 . An oral composition comprising a TTCP salt, a DCPA salt, a first acid and a second acid, wherein said first acid has a solubility in an oral cavity which is greater than the solubility of said second acid.

18 . The oral composition of claim 17 , wherein said composition is a chewing gum having a moisture content of less than about 2 weight percent.

19 . The oral composition of claim 17 , wherein the sum of TTCP salt and DCPA salt in said oral composition is at least about 0.5 percent and less than about 10 percent, based on the total weight of said composition.

20 . An oral composition comprising a TTCP salt, a DCPA salt, a first acid, and a second acid, wherein, upon consumption or mastication of said composition in an oral cavity, dissolution of said first acid begins prior to dissolution of said second acid, such that said oral cavity has (i) a salivary pH that is greater than about 3 and less than about 6 for about the first 60 seconds of consumption or mastication, and thereafter (ii) has a salivary pH that is greater than about 6 and less than about 8, and further wherein the composition has a pH of less than about 6 during said consumption.

21 . The oral composition of claim 20 wherein said composition is a chewing gum having a moisture content of less than about 2 weight percent.

22 . The oral composition of claim 20 , wherein the sum of TTCP salt and DCPA salt in said oral composition is at least about 0.5 percent and less than about 10 percent, based on the total weight of said composition.

23 . A method of remineralizing a dental lesion in the oral cavity of a human, the method comprising placing an oral composition in said oral cavity, wherein said oral composition comprises a calcium phosphate salt, a first acid and a second acid, wherein upon placement of said composition in an oral cavity dissolution of said first acid begins prior to dissolution of said second acid.

24 . The method of claim 23 , wherein said oral composition is present in the oral cavity for at least about 1 minute, at least about 5 minutes, at least about 10 minutes, at least about 20 minutes, at least about 30 minutes or more.

25 . The method of claim 23 , further comprising masticating the oral composition.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Feb 6, 2014
From: COOPERATIEVE CENTRALE RAIFFEISEN-BOERENLEENBANK B.A., "RABOBANK NEDERLAND", NEW YORK BRANCH, AS COLLATERAL AGENT
To: WM. WRIGLEY JR. COMPANY
Reel/Frame 032167/0538 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2012
From: GREENBERG, MICHAEL J; HAAS, MICHAEL S
To: WM. WRIGLEY JR. COMPANY
Reel/Frame 029538/0250 →
SECURITY AGREEMENT Recorded Apr 2, 2012
From: GOLDMAN SACHS CREDIT PARTNERS L.P.
To: WM. WRIGLEY JR. COMPANY
Reel/Frame 027971/0868 →
SECURITY AGREEMENT Recorded Oct 5, 2010
From: WM. WRIGLEY JR. COMPANY
To: COOPERATIEVE CENTRALE RAIFFEISEN-BOERENLEENBANK B.A., "RABOBANK NEDERLAND", NEW YORK BRANCH, AS ADMINISTRATIVE AGENT
Reel/Frame 025095/0013 →
SECURITY AGREEMENT Recorded Oct 7, 2008
From: WM WRIGLEY JR. COMPANY
To: GOLDMAN SACHS CREDIT PARTNERS L.P., AS COLLATERAL AGENT
Reel/Frame 021640/0451 →